| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6766bdb938a144a16e2a50054ee70a02 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
| filingDate |
2001-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b24a0bca5e5a456978cebd27046dc18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c89c77b4aaeec804d91d50babce6597
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ff07fd7a10e49767b5c8557b610e956 |
| publicationDate |
2003-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1285577-A1 |
| titleOfInvention |
Chimeric mouse having an immune system constructed with human cd34-positive cells and use thereof |
| abstract |
Chimeric mice were constructed by transferring human CD34 + cellsn(hematopoietic stem cells) into a SCID mouse. In these chimeric mice,nhematopoietic stem cells persistently differentiated into immunencells. Consequently, the chimeric mice can be immunized over a longntime and enable one to obtain human antibodies against arbitrarynantigens containing a human self-component. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9709574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2185718-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1637591-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2185718-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8715743-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1637591-A1 |
| priorityDate |
2000-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |